Kindred Biosciences Inc. | Mutual Funds
Mutual Funds that own Kindred Biosciences Inc.
Vanguard Total Stock Market Index Fund
807,134
2.39%
41,100
0%
07/31/2018
iShares Russell 2000 ETF
541,680
1.6%
-288
0.02%
09/06/2018
DFA US Small Cap Portfolio
407,649
1.21%
6,400
0.03%
04/30/2018
Vanguard Extended Market Index Fund
393,643
1.17%
300
0.01%
07/31/2018
iShares Russell 2000 Growth ETF
251,434
0.74%
0
0.03%
09/06/2018
DFA US Micro Cap Portfolio
225,467
0.67%
0
0.04%
04/30/2018
PowerShares DWA Small Cap Momentum Portfolio
153,736
0.46%
0
0.5%
09/05/2018
Ariel Discovery Fund
143,585
0.43%
17,600
6.04%
06/30/2018
DFA Tax Managed US Targeted Value Portfolio
136,401
0.4%
0
0.03%
04/30/2018
Fidelity Spartan Extended Market Index Fund
134,240
0.4%
28,815
0.01%
07/31/2018
| Address |
1555 Bayshore Highway
Burlingame California 94010
United States
|
|
Employees
|
- |
| Website |
http://www.kindredbio.com |
| Updated |
07/08/2019 |
| Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA. |
